干扰素治疗继发于 Erdheim-Chester 病的眼眶浸润
Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease.
作者信息
Esmaeli B, Ahmadi A, Tang R, Schiffman J, Kurzrock R
机构信息
Ophthalmology Section, Department of Plastic Surgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
出版信息
Am J Ophthalmol. 2001 Dec;132(6):945-7. doi: 10.1016/s0002-9394(01)01141-2.
PURPOSE
To describe a 55-year-old male with Erdheim-Chester disease with bilateral orbital infiltration and visual loss who was successfully treated with interferon-alpha.
METHODS
Interventional case report.
RESULTS
The patient was treated with interferon-alpha and had an improvement in his clinical signs, including his visual acuity, after 4 weeks of interferon therapy.
CONCLUSION
Interferon-alpha can be effective in the treatment of orbital infiltration secondary to Erdheim-Chester disease.
目的
描述一名55岁患有双侧眼眶浸润和视力丧失的Erdheim-Chester病男性患者，其经α干扰素治疗取得成功。
方法
介入病例报告。
结果
该患者接受α干扰素治疗，在干扰素治疗4周后，包括视力在内的临床体征有所改善。
结论
α干扰素可有效治疗Erdheim-Chester病继发的眼眶浸润。
Zotero 插件